METAL RECOVERY TECHNOLOGIES INC
8-K, 1998-07-15
GOLD AND SILVER ORES
Previous: METAL RECOVERY TECHNOLOGIES INC, 8-K, 1998-07-15
Next: PHOENIX INCOME & GROWTH FUND, N-14, 1998-07-15





                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 8K

                                 CURRENT REPORT

                          Date of Report: July 15, 1998

                           Commission File No. 0-15543
                        METAL RECOVERY TECHNOLOGIES INC.
             (Exact name of Registrant as specified in its charter)


                        Delaware                        71-0628061
             (State of incorporation)       (I.R.S. Employee Identification No.)

                 415 East 151st Street
                 East Chicago, Indiana                    46312
   (Address of principle executive office)              (Zip Code)

       Registrant's telephone number, including area code: (219) 397-6261

Item 5.           Other Events

Cancellation of Performance Shares and Convertible Redeemable Performance Shares

The Company has reached an agreement with the holders of the performance  shares
and the CRPS issued at the time of the company acquisition of MRI(US), Inc. (See
attached  extract  from  the  Company's  for 10K  filing  and  reference  to the
Company's 8K filing dated June 14, 1995.)

The agreed terms are as follows:

Compensation for surrendering 14,000,000 performance shares - $0.00.

Compensation for surrendering  $25,000,000 of CRPS - 20,000,000 common shares of
the Corporations common stock to be issued under Reg S of the SEC.

Signed

/s/

Roy Pearce
Company Secretary
<PAGE>



                        Metal Recovery Technologies, Inc.
                           EXHIBIT - Extract From 10K

ACQUISITION OF MRI(US), Inc.
The acquisition of MRI(US) in 1995 was effected as follows:

         a). By the issue of I  1,000,000  common  shares  under  Regulation  S,
         having a nominal value of $12,000,000,  including  10,000,000 of shares
         at an assigned value of $1.20 each, plus 1,000,000 shares  representing
         the fee to underwriters.

         b). An additional 7,000,000 common shares will be issuable only at such
         time as the dezincing technology of MRI(US) shall have been approved by
         an independent third-party,  as evidenced by such party's entering into
         a contract  with the  Company  for the party,  as evi  processing  of a
         minimum of 50,000 tons per annum of steel scrap utilizing the Company's
         technology,  which contract shall be on commercially  reasonable  terms
         consistent  with a bona  fide  arm's-length  relationship  between  the
         parties,  and,  pursuant thereto,  processing in commercial  quantities
         shall have  commenced  and scrap so processed  shall have been accepted
         and paid for by such third-party.

         c). An  additional  7,000,000  Common  Shares shall be issuable only at
         such time or times as contracts  utilizing the dezincing  technology of
         MRI(US) shall have been entered into with one or more independent third
         parties, providing for the processing of aggregate minimum of 1,000,000
         tons per annum of steel scrap, which contracts shall be on commercially
         reasonable terms consistent with a bona fide arm's-length  relationship
         between the parties.

         d).  $25,000,000 of  Convertible  Redeemable  Preference  Shares ("CRP"
         Shares), shall be issuable upon the following conditions:

                    (1) at the  rate of  $5.00  of CRP  Shares  for  each ton of
                    capacity in dezincing  plants  established by the Company or
                    by any  subsidiary  (excluding  the East Chicago,  IN plant)
                    which is certified as being operable at full capacity and

                    (2) at the rate of $5.00 of CRP  Shares for each ton of such
                    plant capacity,  which achieves normal operation of at least
                    80% of its specified  throughput  capacity over an aggregate
                    of three consecutive months.

  These CRP Shares,  if issued,  will be convertible at the option of the holder
  into shares of common stock of the Company,  or the Company may be required to
  redeem such CPR Shares over a period of four years,  commencing  on the second
  anniversary of issue to the extent of 50% thereof and on each of the third and
  fourth  anniversaries  to the extent of 25%  thereof.  Issuance of  additional
  common  shares  on  conversion  of CRP  Shares,  if  issued,  would  result in
  additional dilution of shareholders equity.

  Determinations as to certification of a plant as being operational,  and as to
  the attainment of requisite 80% of operational capacity,  shall be made by the
  Company in its reasonable good faith  judgment.  Because of delays in bringing
  the  dezincing  process to the point of commercial  viability,  as well as the
  need for  substantial  amounts of capital beyond that  originally  anticipated
  when MRI(US) was  acquired,  the Company  contemplates  seeking to negotiate a
  modification of the conditions  upon which such  additional  common and/or CRP
  shares will be issued.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission